Synthesis and Macrofilaricidal Activity of Substituted 2-Hydroxy/5-Hydroxy/2-Methyl-1,4-Naphthoquinones

被引:5
作者
Karunan, Twinkle [1 ]
Mathew, Nisha [1 ]
Srinivasan, Lakshmy [1 ]
Muthuswamy, Kalyanasundaram [1 ]
机构
[1] Indian Council Med Res, Vector Control Res Ctr, Pondicherry 605006, India
关键词
macrofilaricide; filariasis; naphthoquinone; Setaria digitata; ADME; 1,4-NAPHTHOQUINONE DERIVATIVES; MEDICINAL-PLANTS; STREBLUS-ASPER; NAPHTHOQUINONES; ANTIMALARIAL; ANTIFUNGAL; ANTICANCER; INHIBITORS; SULFONATE; ANALOGS;
D O I
10.1002/ddr.21065
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Preclinical Research Lymphatic filariasis is a disfiguring disease caused by parasitic worms that destroy the human lymphatic system leading to substantial morbidity. The current drug of choice for the treatment of filariasis is diethylcarbamazine and ivermectin with albendazole which are only effective against the microfilaria, leaving the adult worm unaffected, requiring the development of adulticidal drugs. Thirty amino substituted 2-hydroxy/5-hydroxy/2-methyl-1,4-naphthoquinones were synthesized via the reaction of 2-hydroxy/5-hydroxy/2-methyl-1,4-naphthoquinones with different primary and secondary amines. Compounds 130 were evaluated for in vitro antifilarial activity against the adult bovine filarial worm Setaria digitata as assessed by worm motility and MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) reduction assays. The mutagenecity, tumerogenecity, irritantancy, reproductive toxicity, drug score, druglike, and cLogP properties were calculated using OSIRIS property predictor. Ten compounds showed macrofilaricidal activity with ED50 values ranging between 0.086 and 7.6M. Taking into account the biological effects and the promising drug-like profiles of these compounds, these represent valid leads for the development of antifilarial agents against adult filarial worm.
引用
收藏
页码:216 / 226
页数:11
相关论文
共 46 条
[1]  
[Anonymous], ANN TROP MED PARASIT
[2]  
[Anonymous], BIOCH PHARM
[3]  
[Anonymous], DRUG DEV RES
[4]  
[Anonymous], ANAIS ACAD BRASILERI
[5]  
[Anonymous], TRENDS BIOCH SCI
[6]  
[Anonymous], EXPERT OPIN THER PAT
[7]  
[Anonymous], ARCH PHARM RES
[8]  
[Anonymous], MED REV
[9]  
[Anonymous], DRUG DEV RES
[10]  
[Anonymous], PARASITOL RES